These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 6309681
1. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and patients with COLD. Part III: Plasma cyclic AMP. Kreukniet J, Utama I, Hamelink ML. Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):297-300. PubMed ID: 6309681 [Abstract] [Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects. Utama I, Kreukniet J, Fokkens J, Serra R. Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203 [Abstract] [Full Text] [Related]
13. Terbutaline serum concentrations related to different lung function parameters and beta-receptor function. van den Berg W, Leferink JG, Tabingh Suermondt W, Kreukniet J, Maes RA, Serra R, Bruynzeel PL. Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):24-30. PubMed ID: 6299982 [Abstract] [Full Text] [Related]
14. A double-blind comparative trial between two sustained-release theophylline preparations with individual doses in asthmatic in-patients. Van der Meer YG, Van Alphen AC, Van Altena R, Van Loenen AC. Pharm Weekbl Sci; 1982 Dec 17; 4(6):183-90. PubMed ID: 6760111 [Abstract] [Full Text] [Related]
18. Use of serum theophylline level as a guide to optimum therapy in patients with chronic obstructive lung disease. Ashutosh K, Bajaj R, Cho CD, Sangani G. J Clin Pharmacol; 1990 Apr 17; 30(4):324-9. PubMed ID: 2160479 [Abstract] [Full Text] [Related]